Fluidigm (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life sciences and in applied markets. Fluidigm’s systems consist of instruments, software, integrated fluidic circuits (IFCs), high-performance assays for gene expression and genotyping, and pr...

Industry : Biotechnology

Products and Services : Single-Cell Genomics,Gene Expression,SNP Genotyping,Targeted Resequencing,Sample Quantitation,Copy Number Variation,integrated fluidic circuits (IFCs)

Revenues (in million) : $ 125.0000

Employees : 201-500

* If this information is incorrect or inaccurate, please email us at update@datadirectree.com

* If you have any issues with the data displayed here, please email us at info@datadirectree.com